Screener
AngioDynamics ANGO Gross Profit
Gross Profit at other companies
Segments
By segment
Other financials
Where this comes from
Calculated from AngioDynamics’s reported figures.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| Line item | Year ended May 31, 2026 | Year ended May 31, 2025 | Year ended May 31, 2024 |
|---|---|---|---|
| Net sales | $320,174 | $292,498 | $303,914 |
| Cost of sales (exclusive of intangible amortization) | 145,282 | 134,793 | 149,216 |
| Gross margin | 174,892 | 157,705 | 154,698 |
| Operating expenses | |||
| Research and development | 29,447 | 26,222 | 31,512 |
| Sales and marketing | 113,401 | 103,135 | 102,818 |
| General and administrative | 43,691 | 42,092 | 41,164 |
| Amortization of intangibles | 10,682 | 10,318 | 13,048 |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's gross profit?
- AngioDynamics (ANGO) reported gross profit of $46.77M in Q1 2026.
- How has AngioDynamics's gross profit changed year-over-year?
- AngioDynamics's gross profit increased by 10.8% year-over-year, from $42.22M to $46.77M.
- What is the long-term trend for AngioDynamics's gross profit?
- Over 4 years (2022 to 2026), AngioDynamics's gross profit has grown at a 1.4% compound annual growth rate (CAGR), from $165.73M to $174.89M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about AngioDynamics's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude